BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 518259)

  • 1. Cellular and humoral response to Kunin antigen (CA) in ulcerative colitis and Crohn's disease.
    Bartnik W; Kałuzewski S
    Arch Immunol Ther Exp (Warsz); 1979; 27(4):531-8. PubMed ID: 518259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular immune reactions against common antigen, small intestine, and colon antigen in patients with Crohn's disease, ulcerative colitis, and cirrhosis of the liver.
    Eckhardt R; Heinisch M; Meyer zum Büschenfelde KH
    Scand J Gastroenterol; 1976; 11(1):49-54. PubMed ID: 1251132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lipid A antibody titers and O antibody titers in Crohn's disease, ulcerative colitis and acute enteritis (author's transl)].
    Schüssler P; Kruis W; Marget W
    Med Klin; 1976 Oct; 71(44):1898-902. PubMed ID: 825710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Saccharomyces cerevisiae mannan antibodies in inflammatory bowel disease: comparison of different assays and correlation with clinical features.
    Annese V; Piepoli A; Perri F; Lombardi G; Latiano A; Napolitano G; Corritore G; Vandewalle P; Poulain D; Colombel JF; Andriulli A
    Aliment Pharmacol Ther; 2004 Nov; 20(10):1143-52. PubMed ID: 15569117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating antibodies and leucocyte migration inhibition to colon-associated antigen in ulcerative colitis and Crohn's disease.
    Marcussen H; Bendixen G
    Scand J Gastroenterol; 1974; 9(2):149-52. PubMed ID: 4206480
    [No Abstract]   [Full Text] [Related]  

  • 6. [Serodiagnosis of Crohn's disease].
    Auer IO; Wensinck F; Röder A; Merwe JP; Schmidt H; Schuster S
    Dtsch Med Wochenschr; 1983 Aug; 108(33):1242-6. PubMed ID: 6872878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigen specificity of circulating anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease.
    Kossa K; Coulthart A; Ives CT; Pusey CD; Hodgson HJ
    Eur J Gastroenterol Hepatol; 1995 Aug; 7(8):783-9. PubMed ID: 7496870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoresponsiveness in ulcerative colitis and Crohn's disease--effect of colectomy and suppression of disease activity.
    Lyanga J; Davis P; Thomson AB
    West J Med; 1988 Apr; 148(4):421-5. PubMed ID: 3388844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in serum anti-alpha-galactosyl antibodies in patients with Crohn's disease and ulcerative colitis.
    D'Alessandro M; Mariani P; Lomanto D; Bachetoni A; Speranza V
    Clin Immunol; 2002 Apr; 103(1):63-8. PubMed ID: 11987986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibody 1F10 immunoreactivity in inflammatory bowel disease: a new marker specific only for continuous endothelial cells.
    Lügering N; Stoll R; Holzgreve A; Winde G; Sorg C; Domschke W
    Eur J Gastroenterol Hepatol; 1995 Aug; 7(8):777-81. PubMed ID: 7496869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antibody titer to Bacteroides fragilis is increased in Crohn disease patients with fistula development].
    Pietsch M; Brake BA; Schulz TF; Dierich MP
    Z Gastroenterol; 1986 May; 24(5):269-75. PubMed ID: 2425502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of leucocyte migration by antigens from human colon and E. coli O 14 in patients with ulcerative colitis.
    Fixa B; Komárová O; Skaunic V; Nerad M; Kojecký Z; Benỳŝek L
    Scand J Gastroenterol; 1975; 10(5):491-3. PubMed ID: 1098133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential levels of granzyme B, regulatory cytokines, and apoptosis in Crohn's disease and ulcerative colitis at first presentation.
    Jenkins D; Seth R; Kummer JA; Scott BB; Hawkey CJ; Robins RA
    J Pathol; 2000 Feb; 190(2):184-9. PubMed ID: 10657017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study of peripheral leucocyte migration in agarose medium in inflammatory bowel disease.
    Bartnik W; Swarbrick ET; Williams C
    Gut; 1974 Apr; 15(4):294-300. PubMed ID: 4834555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct hospital costs for patients with inflammatory bowel disease in a Canadian tertiary care university hospital.
    Bernstein CN; Papineau N; Zajaczkowski J; Rawsthorne P; Okrusko G; Blanchard JF
    Am J Gastroenterol; 2000 Mar; 95(3):677-83. PubMed ID: 10710056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases.
    Vuckovic S; Florin TH; Khalil D; Zhang MF; Patel K; Hamilton I; Hart DN
    Am J Gastroenterol; 2001 Oct; 96(10):2946-56. PubMed ID: 11693331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunologic studies in patients with Crohn disease and ulcerative colitis].
    Sauer H; Sauer D; Bendix U; Schumann B
    Allerg Immunol (Leipz); 1984; 30(1):23-33. PubMed ID: 6203390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukocyte migration inhibitory factor (LMIF) release by human colonic lymphocytes.
    Bartnik W; ReMine SG; Shorter RG
    Arch Immunol Ther Exp (Warsz); 1981; 29(3):397-405. PubMed ID: 6271090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro cellular cytotoxicity in Crohn's disease and ulcerative colitis: relation with disease activity and treatment, and the effect of recombinant gamma-interferon.
    Aparició-Pagés MN; Verspaget HW; Peña AS; Weterman IT; de Bruin PA; Mieremet-Ooms MA; van der Zon JM; van Tol EA; Lamers CB
    J Clin Lab Immunol; 1989 Jul; 29(3):119-24. PubMed ID: 2517428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease.
    Dotan I; Fishman S; Dgani Y; Schwartz M; Karban A; Lerner A; Weishauss O; Spector L; Shtevi A; Altstock RT; Dotan N; Halpern Z
    Gastroenterology; 2006 Aug; 131(2):366-78. PubMed ID: 16890590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.